The importance of MICA/NKG2D engagement in the control of cancer has been demonstrated by several studies showing that increased soluble MICA protein in the serum of cancer patients leads to downregulation of NKG2D on NK cells and correlates to poor prognosis (92). This evidence concerns the gene MICA and cancer.